Plain English Summary
Background and study aims
It is common for many adults and elderly people to have difficulty swallowing tablets or capsules. The School of Pharmacy at the University of East Anglia have developed a jelly-like product designed to enclose tablets making them easier to swallow, without the need for water. The aim of this study is to determine whether the gel swallowing aid has any effect on the absorption of the enclosed drug.
Who can participate?
We are looking to recruit twelve healthy male volunteers, between the ages of 18 and 35 years.
What does the study involve?
Taking part will involve the volunteer attending two morning sessions, at least one week apart. The volunteer will be asked to swallow an aspirin tablet either with the gel swallowing aid or with water, one at each visit. Six blood samples will be taken over the course of two hours. The volunteers will also be asked to complete a short questionnaire at each visit relating to the ease and comfort of the swallow.
What are the possible benefits and risks of participating?
There are no direct benefits to taking part in the study, however as a thank you for their time, volunteers will receive £50, travel expenses and lunch at each visit. The risks from taking part in the study are very low. The components of the gel swallowing aid are all routinely used in food products. The gel is designed to melt / dissolve quickly when in contact with the body, therefore choking is unlikely. Each volunteer will be given Weetabix and milk before being administered the aspirin tablet in order to protect the stomach against any irritation.
Where is the study run from?
The study will be run in the Clinical Research and Trials Unit at the Norfolk and Norwich University Hospital, Norwich.
When is the study starting and how long is it expected to run for?
January 2013 to March 2013
Who is funding the study?
Medical Research Council (UK)
Who is the main contact?
Prof John Potter
+44 1603 59 1755
Bioequivalence study of a gel swallowing aid: a randomised study
A new formulation, containing ingredients all commonly used in food, has been developed as a gel to aid tablet administration in patients with swallowing difficulties (dysphagia). The study hopes to establish, using healthy volunteers, whether the gel affects the absorption of drug from the incorporated tablet in any way.
NRES Committee East of England Cambridge East, 18th June 2012, ref: 12/EE/0097/AM01
Randomised; Interventional; Design type: Process of Care, Treatment
Primary study design
Secondary study design
Randomised controlled trial
Patient information sheet
Not available in web format, please use the contact details below to request a patient information sheet
Each volunteer will be administered an aspirin tablet both with and without the gel swallowing aid on two separate occasions. Six blood samples will be taken over the course of two hours on each occasion. Volunteers will also be asked to complete a short questionnaire relating to the ease and comfort of swallowing the tablet in each scenario.
Twelve volunteers will be recruited from the University of East Anglia and the Norfolk and Norwich University Hospital to swallow a tablet (300mg aspirin) encapsulated within the gel, and also the tablet without the gel. The volunteers will be asked to provide blood samples at time points along the absorption process to determine the blood serum concentration of aspirin metabolites. The effect on platelets will also be determined. It is envisaged that the study will last a total of 6 hours (3 hours on two separate occasions) for each volunteer. The gels will be prepared up to twenty four hours in advance in the hospital pharmacy and stored at room temperature.
Primary outcome measures
Safety of the gel i.e. to ensure the gel can be administered safely without unacceptable adverse effects.
Secondary outcome measures
To assess the acceptability of the gel swallowing aid using a questionnaire relating to ease and comfort of swallowing the tablet with and without the gel.
Overall trial start date
Overall trial end date
Participant inclusion criteria
Healthy male volunteers aged 18 to 35
Target number of participants
Planned Sample Size: 12; UK Sample Size: 12
Participant exclusion criteria
1. Participants who dont eat or are allergic to gelatin, hydroxypropyl methylcellulose (HPMC), citric acid or potassium sorbate
2. Patients who suffer with dysphagia or difficulty swallowing
3. Participants who are allergic to aspirin or any other Nonsteroidal anti-inflammatory drugs (NSAIDs)
4. Participants with hypersensitivity to aspirin i.e. attacks of asthma, angioedema, urticaria or rhinitis precipitated by aspirin or any other NSAID
5. Participants who have active peptic ulceration.
6. Participants who have haemophilia or other bleeding disorders
7. Participants taking aspirin regularly or who have taken in the last 7 days
8. Participants who are taking other medications, particularly those containing salicylates
9. Patients with parallel participation in another research study
10. Any person related to or living with any member of the study team
11. Any person with language difficulties
Recruitment start date
Recruitment end date
Countries of recruitment
Trial participating centre
Norfolk and Norwich University Hospital NHS Trust (UK)
Medical Research Council (MRC) (UK)
Funding Body Type
private sector organisation
Funding Body Subtype
Results and Publications
Publication and dissemination plan
Not provided at time of registration
Intention to publish date
Participant level data
Not provided at time of registration
Results - basic reporting